Org-NC45: a new steroidal non-depolarizing muscle relaxant
- PMID: 6122196
- DOI: 10.1007/BF02112349
Org-NC45: a new steroidal non-depolarizing muscle relaxant
Abstract
Although pancuronium has fewest side effects compared to other currently used non-depolarizing muscle relaxants, it is still not the ideal relaxant. Its structural analogues have been studied to derive such an ideal relaxant. Org-NC45 meets the requirements for such a relaxant best and is therefore extensively studied. It is more potent than pancuronium, has a shorter onset and duration of action and is free from cardiovascular side effects. Histamine release could not be demonstrated. It can be easily reversed by neostigmine, pyridostigmine or 4-aminopyridine. Interaction with antibiotics and anaesthetic drugs is not different from that of pancuronium.
Similar articles
-
Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.Anesthesiology. 1981 Jul;55(1):6-11. doi: 10.1097/00000542-198107000-00003. Anesthesiology. 1981. PMID: 6113794
-
Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.Can Anaesth Soc J. 1982 Nov;29(6):567-72. doi: 10.1007/BF03007742. Can Anaesth Soc J. 1982. PMID: 6128068
-
Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45.Acta Anaesthesiol Scand. 1980 Oct;24(5):423-5. doi: 10.1111/j.1399-6576.1980.tb01576.x. Acta Anaesthesiol Scand. 1980. PMID: 6110303
-
[Role of vecuronium in comparison with curariform drugs used in man].Ann Fr Anesth Reanim. 1983;2(1):35-8. doi: 10.1016/s0750-7658(83)80048-3. Ann Fr Anesth Reanim. 1983. PMID: 6137981 French.
-
Clinical relaxation: current controversy.Can Anaesth Soc J. 1986 May;33(3 Pt 2):S1-4. doi: 10.1007/BF03019148. Can Anaesth Soc J. 1986. PMID: 2872951 Review. No abstract available.